Conghua Xie

Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer

W. Feng, Jialei Wang, Xiaolong Yan, 2023, Thoracic cancer.

Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer.

Xiangyu Pan, J. Xue, R. Tong, 2024, Med.

Pan-cell death-related signature reveals tumor immune microenvironment and optimizes personalized therapy alternations in lung adenocarcinoma

Linzhi Han, Conghua Xie, Jingyi He, 2024, Scientific reports.

Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion

Junhong Zhang, Fajian He, Linzhi Han, 2024, Cancer immunology, immunotherapy : CII.

hsa-miR-1301-3p Promotes the Proliferation and Migration of Nonsmall Cell Lung Cancer Cells and Reduces Radiosensitivity via Targeting Homeodomain-Only Protein Homeobox.

Wen-jie Sun, Zhengrong Huang, Linzhi Han, 2023, Genetic testing and molecular biomarkers.

Targeting the LMP1-ALIX axis in EBV+ nasopharyngeal carcinoma inhibits immunosuppressive small extracellular vesicle secretion and boosts anti-tumor immunity.

Fajian He, Yanping Gao, Linzhi Han, 2024, Cancer communications.